← Open Payments lookup

STEVEN SOMOGYI: Open Payments

NPI 1558468090 · PERTH AMBOY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$757 in 43 payments from 14 companies in 2025. Trend: 2023 $50 · 2024 $319 · 2025 $757

Food & beverage: $757
CompanyPaymentsAmount
Novo Nordisk Inc14$219
AstraZeneca Pharmaceuticals LP5$78
Exact Sciences Corporation3$75
Lilly USA, LLC4$67
Otsuka America Pharmaceutical, Inc.3$60
Boehringer Ingelheim Pharmaceuticals, Inc.3$53
Phathom Pharmaceuticals, Inc.2$38
PFIZER INC.2$37
Teva Pharmaceuticals USA, Inc.2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27

Products named: Ozempic, Rybelsus, The Cologuard Plus Collection Kit, MOUNJARO, REXULTI, JARDIANCE, BREZTRI, VOQUEZNA.

Industry payments across NJ — which companies pay providers there.